Viridian Therapeutics, Inc.\DE (VRDN) Other Working Capital Changes (2013 - 2026)

Viridian Therapeutics, Inc.\DE's Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$72000.0 for Q2 2025.

• In Q2 2025, Other Working Capital Changes changed 0.0% year-over-year to -$72000.0; the TTM figure through Jun 2025 stood at -$288000.0 (changed 0.0% YoY), while the FY2024 annual figure was -$288000.0, changed 0.0% from the prior year.
• Other Working Capital Changes for Q2 2025 stood at -$72000.0, roughly flat from -$72000.0 in the prior quarter.
• The five-year high for Other Working Capital Changes was $8.6 million in Q4 2025, with the low at -$5.2 million in Q2 2025.
• The 5-year median for Other Working Capital Changes is $780000.0 (2022), against an average of $1.1 million.
• Peak annual rise in Other Working Capital Changes reached 51.68% in 2022, while the deepest fall reached 107.76% in 2022.
• Viridian Therapeutics, Inc.\DE's Other Working Capital Changes stood at -$71000.0 in 2021, then retreated by 1.41% to -$72000.0 in 2022, then changed by 0.0% to -$72000.0 in 2023, then changed by 0.0% to -$72000.0 in 2024, then changed by 0.0% to -$72000.0 in 2025.
• Business Quant data shows VRDN's Other Working Capital Changes at -$72000.0 in Q2 2025, -$72000.0 in Q1 2025, and -$72000.0 in Q4 2024.